163 related articles for article (PubMed ID: 6858868)
1. Electrophysiologic testing in the management of patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
Morady F; Sledge C; Shen E; Sung RJ; Gonzales R; Scheinman MM
Am J Cardiol; 1983 Jun; 51(10):1623-8. PubMed ID: 6858868
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.
Waspe LE; Brodman R; Kim SG; Fisher JD
Am Heart J; 1986 Dec; 112(6):1141-52. PubMed ID: 3788760
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern.
Milstein S; Sharma AD; Klein GJ
Am J Cardiol; 1986 May; 57(13):1097-100. PubMed ID: 3706161
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: role of pulmonary veins.
Derejko P; Szumowski LJ; Sanders P; Krupa W; Bodalski R; Orczykowski M; Urbanek P; Zakrzewska J; Lim HS; Lau DH; Kuśnierz J; Walczak F
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):280-6. PubMed ID: 22035173
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.
Hu J; Yu J; Chen Q; Hu J; Huang Q; Xia Z; Xia Z; Ju Z; Yuan P; Fan S; Xiong Q; Zhu B; Huang L; You C; Bao H; Wu Y; Cheng X; Li J; Marian AJ; Hong K
J Am Heart Assoc; 2019 Jul; 8(13):e012511. PubMed ID: 31234695
[TBL] [Abstract][Full Text] [Related]
7. [The clinical features and long-term follow-up of atrial fibrillation or atrial flutter complicating Wolff-Parkinson-White syndrome].
Wang Q; Pu S; Cai N
Zhonghua Nei Ke Za Zhi; 1996 Mar; 35(3):153-6. PubMed ID: 9387649
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
Hamada T; Hiraki T; Ikeda H; Kubara I; Yoshida T; Ohga M; Imaizumi T
J Cardiovasc Electrophysiol; 2002 Mar; 13(3):223-9. PubMed ID: 11942586
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
Centurión OA; Shimizu A; Isomoto S; Konoe A
Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern.
Szabo TS; Klein GJ; Sharma AD; Yee R; Milstein S
Am J Cardiol; 1989 Jan; 63(3):187-92. PubMed ID: 2909998
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway.
Sharma AD; Klein GJ; Guiraudon GM; Milstein S
Circulation; 1985 Jul; 72(1):161-9. PubMed ID: 4006127
[TBL] [Abstract][Full Text] [Related]
13. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
[TBL] [Abstract][Full Text] [Related]
14. Atrial electrophysiological features in patients with Wolff-Parkinson-White and atrial fibrillation: absence of rate adaptation of intraatrial conduction time parameters.
Riccardi R; Gaita F; Giustetto C; Gardiol S
Pacing Clin Electrophysiol; 1997 May; 20(5 Pt 1):1318-27. PubMed ID: 9170133
[TBL] [Abstract][Full Text] [Related]
15. Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
Varriale P; Sedighi A; Mirzaietehrane M
Pacing Clin Electrophysiol; 1999 Aug; 22(8):1267-9. PubMed ID: 10461309
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological features of orthodromic atrioventricular reentry tachycardia in patients with wolff-Parkinson-white syndrome and atrial fibrillation.
Kalarus Z; Kowalski O; Lenarczyk R; Prokopczuk J; Pasyk S
Pacing Clin Electrophysiol; 2003 Jul; 26(7 Pt 1):1479-88. PubMed ID: 12914625
[TBL] [Abstract][Full Text] [Related]
17. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
[TBL] [Abstract][Full Text] [Related]
18. Relation of syncope in young patients with Wolff-Parkinson-White syndrome to rapid ventricular response during atrial fibrillation.
Paul T; Guccione P; Garson A
Am J Cardiol; 1990 Feb; 65(5):318-21. PubMed ID: 2301260
[TBL] [Abstract][Full Text] [Related]
19. Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndrome.
Rinkenberger RL; Naccarelli GV; Miles WM; Markel ML; Dougherty AH; Prystowsky EN; Heger JJ; Zipes DP
Am J Cardiol; 1988 Dec; 62(19):26L-30L. PubMed ID: 3144164
[TBL] [Abstract][Full Text] [Related]
20. Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
Klein GJ; Bashore TM; Sellers TD; Pritchett EL; Smith WM; Gallagher JJ
N Engl J Med; 1979 Nov; 301(20):1080-5. PubMed ID: 492252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
